Takanori Yokota

Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators.

Rena Therapeutics Inc. engages in the provision of third platform technology specifically for creation of new nucleic acid drugs. It offers joint collaborative search business, basic technology licensing and nucleic acid drug development business. The company was founded by Junichi Yano, Takashi Yamamoto and Takanori Yokota on January 15, 2015 and is headquartered in Tokyo, Japan.